Asset Details
Do you wish to reserve the book?
The Interplay between Fe 3 O 4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Interplay between Fe 3 O 4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport
Do you wish to request the book?
The Interplay between Fe 3 O 4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Interplay between Fe 3 O 4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport
2020
Overview
Combined treatments which use nanoparticles and drugs could be a synergistic strategy for the treatment of a variety of cancers to overcome drug resistance, low efficacy, and high-dose-induced systemic toxicity. In this study, the effects on human colon adenocarcinoma cells of surface modified Fe
O
magnetic nanoparticles (MNPs) in combination with sodium butyrate (NaBu), added as a free formulation, were examined demonstrating that the co-delivery produced a cytotoxic effect on malignant cells. Two different MNP coatings were investigated: a simple polyethylene glycol (PEG) layer and a mixed folic acid (FA) and PEG layer. Our results demonstrated that MNPs with FA (FA-PEG@MNPs) have a better cellular uptake than the ones without FA (PEG@MNPs), probably due to the presence of folate that acts as an activator of folate receptors (FRs) expression. However, in the presence of NaBu, the difference between the two types of MNPs was reduced. These similar behaviors for both MNPs likely occurred because of the differentiation induced by butyrate that increases the uptake of ferromagnetic nanoparticles. Moreover, we observed a strong decrease of cell viability in a NaBu dose-dependent manner. Taking into account these results, the cooperation of multifunctional MNPs with NaBu, taking into consideration the particular cancer-cell properties, can be a valuable tool for future cancer treatment.
Subject
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Cell Survival - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - metabolism
/ Drug Delivery Systems - methods
/ Ferric Compounds - chemistry
/ Folate Receptors, GPI-Anchored - metabolism
/ Humans
